A ‘Patient Day’ for a global ‘Patient Culture’: promoting active learning around patients’ needs to all employees. The goal is that all employees better understand and live the company motto “We put patients first”.
On Friday, September 21st, Nemera’s French plants at La Verpillière and Le Tréport organized the first Nemera ‘Patient Day’, an internal event to increase employee awareness of patients’ needs and conditions. More than 50 employees organized many different activities such as conferences, disease impact simulations, games and hospital visits. Conference themes ranged from understanding asthma to the role of pharmacists in relation to patients to the prevention of cardiovascular diseases. Employees experienced many aspects of the lives and challenges faced by patients thanks to similations related to eye diseases, arthritis and tremors.
They also participated in healthcare-themed escape games, tried out the devices manufactured by Nemera, experienced emergency injection procedure under stress or went out to visit the ophthalmological department at a neighbouring hospital. The same event will also be organized in the German plant in Neuenburg on November 14th, World Diabetes Day.
Marc Hämel, Nemera’s CEO, was enthusiastic after the success of the event: “We are proud to put the patient at the core of everything we do and deliver innovative high quality devices that make it easier for patients to follow their treatment.” – he added – “It is very important for our employees to be engaged and exposed, not only to our products but also to the people who use them. This will contribute to achieving our vision: to become the most patient-centric drug delivery devices company.”
Nemera would also like to share its commitment to patients at tradeshows and conferences. During the upcoming trade fairs to be attended by Nemera, the PDA conference in Orlando and CphI Worlwide in Madrid, the company will invite visitors to put themselves in the shoes of visually impaired patients with glasses simulating ocular diseases such as glaucoma or diabetic retinopathy.”